Akorn, Inc. recalls Eptifibatide Injection, 75 mg/100 mL (0.75 mg/mL), 100 mL Single-use Vial, For Intravenous Use Only, Rx Only, Manufactur
Recalled September 4, 2019 · FDA recall D-1839-2019 · Akorn
Hazard
Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid. · FDA Class III
Units
4085 vials
Sold at
Nationwide in the U.S.
Description
Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.
Product
Eptifibatide Injection, 75 mg/100 mL (0.75 mg/mL), 100 mL Single-use Vial, For Intravenous Use Only, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-903-90.
Manufacturer(s)
Akorn, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →